Pharmaceutical - Fresenius Kabi

Filter

Current filters:

Fresenius Kabi

Popular Filters

Fresenius Kabi to invest A$47 million in Australian production plant

01-03-2014

Germany-based Fresenius Kabi is establishing a A$47 million ($42 million) state-of-the-art pharmaceutical…

Asia-PacificAustraliaFresenius KabiPharmaceuticalProduction

Fresenius gets US FDA warning over Indian plant; divests biotech unit

09-07-2013

Germany-based Fresenius Kabi has received a warning letter from the US Food and Drug Administration in…

Fresenius BiotechFresenius KabiMergers & AcquisitionsNeoPharmPharmaceuticalRegulationRemovab

Fresenius Kabi sells respiratory homecare business in France

17-12-2012

Germany-based Fresenius Kabi, a provider of infusion therapy and clinical nutrition. has signed an agreement…

BiotechnologyFresenius BiotechFresenius KabiMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

Fresenius Kabi to acquire Fenwal

23-07-2012

Germany-based Fresenius Kabi, a provider of infusion therapy and clinical nutrition, has reached a definitive…

FenwalFresenius KabiMergers & AcquisitionsPharmaceutical

The Medicines Co settles with APP over Angiomax

24-01-2012

The Medicines Company (Nasdaq: MDCO) says that it has settled the law suits filed by company in the US…

AngiomaxAPP PharmaceuticalsCardio-vascularFresenius KabiGenericsLegalNorth AmericaPatentsPharmaceuticalThe Medicines Company

Back to top